Fundz

Mebias Discovery reported raising $631,000 in an initial SEC Form D filing, from an offering of $2.05 Million

PRIVATESep 23, 2022$630.7K of $2M raised

Amount Raised

$631,000

$631,000 sold, per SEC Form D (first sale Sep 15, 2022)

Round Type

Seed

PhiladelphiaHealthcare

Quick answer

Mebias Discovery, Inc. raised $631,000 in a Seed round, dated September 15, 2022. Mebias Discovery, Inc. is based in Philadelphia, Pennsylvania, United States.

How much did Mebias Discovery, Inc. raise?
Mebias Discovery, Inc. raised $631,000 in a Seed round on September 15, 2022.
What does Mebias Discovery, Inc. do?
MEBIAS’ business model is comprised of partnering and advancing its own molecules into early clinical development.
Where is Mebias Discovery, Inc. based and how big is it?
Mebias Discovery, Inc. is based in Philadelphia, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Mebias Discovery, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • EmOpti raised $425K (Seed) on October 29, 2022.
  • Spectral Medical raised $2.7M (Seed) on October 28, 2022.
  • Imagen Dental Partners raised $80K on October 28, 2022.
  • WiscMed raised $2M on October 28, 2022.
  • Voltron Therapeutics, Inc. raised $515K (Seed) on October 28, 2022.
  • Everus Health raised $1M (Seed) on October 28, 2022.

Who to call at Mebias Discovery, Inc., and when

A new round usually means Mebias Discovery, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mebias Discovery, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mebias Discovery, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mebias Discovery, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mebias Discovery, Inc.

Location

3675 MARKET STREET, SUITE 200

Philadelphia, Pennsylvania, United States

About

MEBIAS’ business model is comprised of partnering and advancing its own molecules into early clinical development. Six years since its founding, the company has validated its unique drug discovery, identified a novel preclinical mu-opioid candidate entering Phase 1 human clinical studies in 2022, and currently developing Sphingosine 1-phosphate receptor (S1PR1) agonists for the treatment of neuropathic pain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mebias Discovery, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mebias Discovery, Inc.'s next move

See what Strategic adds

Mebias Discovery, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.